Vitrakvi 50419-0393-03
Generic: Larotrectinib
- Manufacturer
- Bayer Healthcare Pharmaceuticals Inc.
- Dosage Form
- Solution, Concentrate
- Route
- Oropharyngeal
- Product Type
- Human Prescription Drug
- Marketing Start
- December 6, 2022
- Listing Expires
- December 31, 2027
- Application
- NDA211710
Need to source Vitrakvi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Larotrectinib | 20 mg/mL |
Drug Class
Kinase Inhibitor [EPC]Kinase Inhibitor [EPC]Tropomyosin Receptor Kinases Inhibitors [MoA]
Selected Package
50419-0393-03Selected2 BOTTLE in 1 CARTON (50419-393-03) / 50 mL in 1 BOTTLE (50419-393-02)